GREGORY D. PERRY - 16 Jun 2022 Form 4 Insider Report for Kala Pharmaceuticals, Inc. (KALA)

Role
Director
Signature
/s/ Mary Reumuth, Attorney-in-Fact
Issuer symbol
KALA
Transactions as of
16 Jun 2022
Net transactions value
$0
Form type
4
Filing time
17 Jun 2022, 16:45:38 UTC
Previous filing
02 Jun 2022
Next filing
02 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KALA Stock Option (right to buy) Award $0 +40,000 $0.000000 40,000 16 Jun 2022 Common Stock 40,000 $0.3600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 16, 2022 and will vest as to 100% of the shares underlying the option on the earlier of (i) June 16, 2023 or (ii) the date of the first annual meeting following June 16, 2022.